↑ Rising
Business
Novartis to Buy Myricx Bio for Up to $1.5 Billion
Novartis has announced a deal to acquire UK-based cancer biotech firm Myricx Bio for as much as $1.5 billion.
Myricx Bio
1 trends tracked about this subject — the full history, oldest to newest below.